Designing and execution capabilities.
Experienced management team and a motivated and efficient work force.
Cordial relations with our consumers.
Quality assurance and control.
Changes in technology or failures to upgrade or adapt changes may render its existing Exim Routes
Intelligence System ("ERIS") technology obsolete and require significant investments, which may impact
the company's business and financial condition.
Regulatory restrictions on wastepaper trading, including import/export norms and environmental
compliance, may impact business operations. Changes in policy or classification standards could disrupt
supply chains and affect material availability.
The company's major revenue is sourced from trading of Paper Recyclables. The company's inability or failures to manage and
attract more clients in this segment could adversely affect its business.
The demand for recyclable paper is cyclical and influenced by market trends and economic conditions. This
variability can lead to fluctuations in revenue and profit margins over time.
The company's business is subject to risks relating to high trade receivables, which may adversely affect its cash flows,
results of operations and financial condition.
The company's business is working capital intensive, and fluctuations or inadequate financing of its working capital
requirements may adversely affect the company's business, financial condition, and results of operations.
The property used by the company as its registered office is not owned by the company. Any termination of
the relevant lease/ rent agreements could adversely affect its operations.
Failures to complete the acquisition/fit outs completion on time will delay the capex etc which can adversely
affect its business operations, financial results and cash flow positions.
Significant security breaches, system failures, and fraud within our computer systems and network
infrastructure may adversely affect its business operations, financial condition, cash flows, and results of
operations.
The company's proposed capital expenditure relating to investment in development of its product "ERIS" is subject to
the risk of unanticipated delays in implementation and cost overruns.